02/21/2018 | Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical | Los Angeles District Office | Compounding Pharmacy/Adulterated Drug Products | Not Issued * |
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Tuesday, May 1, 2018
Chinese API maker Yinghua hit with FDA warning letter
Tuesday, May 1, 2018
Chinese API maker Yinghua Biochemical and Pharmaceutical Co. was issued a warning letter by the FDA for data integrity issues and problems with its quality unit
|
HHS Inspector General Dan Levinson Shares the OIG’s Latest Perspectives [Podcast]
By Adam Turteltaub adam.turteltaub@Read on »
Subscribe to:
Posts (Atom)